The effect of the polymorphism in IL-28B gene on the treatment response of a combined therapy by sofosbuvir and daclatasvir with and without ribavirin in HCV Egyptian patients

TM6SF2 and NCAN polymorphism impact on HCV in North African Egyptian patients

Impact of direct-acting antiviral therapy in Egyptian patients with chronic hepatitis C and liver cirrhosis

Polymorphisms of glutathione peroxidase-1 gene in Egyptian Patients with Chronic Hepatitis C Virus

Human Catalase Polymorphisms in Egyptian Patients with Chronic Hepatitis C Virus

Genetic Variants in ITPA and TNFSF10A Are Associated with the Risk of HCV Infection Among Egyptian Populations

Association of multiple mutations in NS5A and NS5B genes and resistance to direct-acting antivirals in chronically infected Egyptian patients with Hepatitis C virus Genotype 4a

Genetic variability of NS5B region of Hepatitis C Virus patients in Egypt

The Link between an Epidermal Growth Factor Gene Functional Polymorphism and Hepatocellular Carcinoma in a Cohort of Hepatitis C Egyptian Patients

SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS